ULTRAGENYX PHARMACEUTICAL INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2016 | $133.0K | $-248.0M | $-245.9M |
| FY2017 | $2.6M | $-328.9M | $-302.1M |
| FY2018 | $51.5M | $-371.4M | $-197.6M |
| FY2019 | $103.7M | $-424.2M | $-402.7M |
| FY2020 | $271.0M | $-330.1M | $-186.6M |
| FY2021 | $351.4M | $-381.7M | $-454.0M |
| FY2022 | $363.3M | $-648.9M | $-707.4M |
| FY2023 | $434.0M | $-569.0M | $-607.0M |
| FY2024 | $560.0M | $-536.0M | $-569.0M |
| FY2025 | $673.0M | $-535.0M | $-575.0M |